Conjugated linoleic acid suppresses the migratory and inflammatory phenotype of the monocyte/macrophage cell

Atherosclerosis

Volumn 211, Issue 1, 2010, Pages 96-102

  McClelland, Sarah ^a   Cox, Clare ^a   O'Connor, Roisin ^b   de Gaetano, Monica ^a   McCarthy, Cathal ^a   Cryan, Lorna ^c   Fitzgerald, Des ^a   Belton, Orina ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Conjugated linoleic acid; Cyclooxygenase; Monocyte migration; PPARs

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CONJUGATED LINOLEIC ACID; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2; GELATINASE B; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN E2; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CHROMAN DERIVATIVE; PHOSPHOLIPASE A2; TROGLITAZONE;

ARTICLE; ATHEROSCLEROSIS; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; ISOMER; MACROPHAGE MIGRATION; MONOCYTE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; ZYMOGRAPHY; BIOSYNTHESIS; CELL MOTION; DRUG EFFECTS; MACROPHAGE; METABOLISM; PHYSIOLOGY;

CELL MOVEMENT; CHEMOKINE CCL2; CHROMANS; CYCLOOXYGENASE 2; DINOPROSTONE; HUMANS; LINOLEIC ACIDS, CONJUGATED; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MONOCYTES; PHOSPHOLIPASES A2; PPAR GAMMA; RECEPTORS, CCR2; THIAZOLIDINEDIONES;

EID: 77954314660     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.02.003     Document Type: Article

References (30)

1. Arbonés-Mainar J.M., Navarro M.A., Guzmán M.A., et al. Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice. Atherosclerosis 2006, 189:318-327.
2. Navarro V., Zabala A., Macarulla M.T., et al. Effects of conjugated linoleic acid on body fat accumulation and serum lipids in hamsters fed an atherogenic diet. J Physiol Biochem 2003, 59:193-199.
3. Kritchevsky D., Tepper S.A., Wright S., Tso P., Czarnecki S.K. Influence of conjugated linoleic acid on establishment and progression of atherosclerosis in rabbits. J Am Coll Nutr 2000, 19:472-477.
4. Toomey S., Harhen B., Roche H.M., Fitzgerald D., Belton O. Profound resolution of early atherosclerosis with conjugated linoleic acid. Atherosclerosis 2006, 187:40-49.
5. Massberg S., Brand K., Grüner S., et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002, 196:887-896.
6. Shah P.K., Falk E., Badimon J.J., et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995, 92:1565-1569.
7. Li A.C., Brown K.K., Silvestre M.J., Willson T.M., Palinski W., Glass C.K. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2000, 106:523-531.
8. Chen Z., Ishibashi S., Perrey S., et al. Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL. Arterioscler Thromb Vasc Biol 2001, 21:372-377.
9. Pasceri V., Wu H.D., Willerson J.T., Yeh E.T. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activaed receptor-gamma activators. Circulation 2000, 101(3):235-238.
10. Bozzo F., Bocca C., Colombatto S., Miglietta A. Antiproliferative effect of conjugated linoleic acid in caco-2 cells: involvement of PPARgamma and APC/beta-catenin pathways. Chem Biol Interact 2007, 169:110-121.
11. Bergamo P., Luongo D., Maurano F., Mazzarella G., Stefanile R., Rossi M. Conjugated linoleic acid enhances glutathione synthesis and attenuates pathological signs in MRL/MpJ-Fas(lpr) mice. J Lipid Res 2006, 47:2382-2391.
12. Belton O., Byrne D., Kearney D., Leahy A., Fitzgerald D.J. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation 2000, 102:840-845.
13. Iwakiri Y., Sampson D.A., Allen K.G. Suppression of cyclooxygenase-2 and inducible nitric oxide synthase expression by conjugated linoleic acid in murine macrophages. Prostaglandins Leukot Essent Fatty Acids 2002, 67:435-443.
14. Ringseis R., Schulz N., Saal D., Eder K. Troglitazone but not conjugated linoleic acid reduces gene expression and activity of matrix-metalloproteinases-2 and -9 in PMA-differentiated THP-1 macrophages. J Nutr Biochem 2008, 19:594-603.
15. Chan E.S., Zhang H., Fernandez P., et al. Effect of cyclooxygenase inhibition on cholesterol efflux proteins and atheromatous foam cell transformation in THP-1 human macrophages: a possible mechanism for increased cardiovascular risk. Arthritis Res Ther 2007, 9:R4.
16. Coppinger J.A., Cagney G., Toomey S., et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004, 103:2096-2104.
17. Soel S.M., Choi O.S., Bang M.H., Yoon Park J.H., Kim W.K. Influence of conjugated linoleic acid isomers on the metastasis of colon cancer cells in vitro and in vivo. J Nutr Biochem 2007, 18:650-657.
18. Gosling J., Slaymaker S., Gu L., et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 1999, 103:773-778.
19. Massberg S., Schürzinger K., Lorenz M., et al. Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation 2005, 112:1180-1188.
20. McClelland S., Gawaz M., Kennerknecht E., et al. Contribution of cyclooxygenase-1 to thromboxane formation, platelet-vessel wall interactions and atherosclerosis in the ApoE null mouse. Atherosclerosis 2009, 202:84-91.
21. Huo Y., Schober A., Forlow S.B., et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003, 9:61-67.
22. Coppinger J.A., O'Connor R., Wynne K., et al. Moderation of the platelet releasate response by aspirin. Blood 2007, 109:4786-4792.
23. Kintscher U., Goetze S., Wakino S., et al. Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes. Eur J Pharmacol 2000, 401:259-270.
24. Babaev V.R., Yancey P.G., Ryzhov S.V., et al. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 2005, 25:1647-1653.
25. Belton O.A., Duffy A., Toomey S., Fitzgerald D.J. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis. Circulation 2003, 108:3017-3023.
26. Ringseis R., Gahler S., Herter C., Eder K. Conjugated linoleic acids exert similar actions on prostanoid release from aortic and coronary artery smooth muscle cells. Int J Vitam Nutr Res 2006, 76:281-289.
27. Stachowska E., Dziedziejko V., Safranow K., et al. Inhibition of phospholipaseA(2) activity by conjugated linoleic acids in human macrophages. Eur J Nutr 2007, 46:28-33.
28. Panzer U., Uguccioni M. Prostaglandin E2 modulates the functional responsiveness of human monocytes to chemokines. Eur J Immunol 2004, 34:3682-3689.
29. Tajima T., Murata T., Aritake K., et al. Lipopolysaccharide induces macrophage migration via prostaglandin D(2) and prostaglandin E(2). J Pharmacol Exp Ther 2008, 326:493-501.
30. Waldo S.W., Li Y., Buono C., et al. Hetergeneity of human macrophages in culture and in atherosclerotic plaques. Am J Pathol 2008, 172(4):1112-1126.